GHB/GBL intoxication and withdrawal
GHB/GBL · Psychiatry / Behavioural
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Gamma-hydroxybutyrate (GHB) and its prodrug GBL cause rapid-onset deep coma with abrupt recovery, often with a narrow margin between euphoria and respiratory arrest. Dependence produces a severe, benzodiazepine-resistant withdrawal syndrome resembling delirium tremens. Both are medical emergencies.
Red flags
- Respiratory depression or apnoea (overdose)
- GCS not improving as expected (suspect co-ingestant or other cause)
- Autonomic instability, hyperthermia or seizures (withdrawal)
- Delirium progressing despite benzodiazepines
- Aspiration or airway compromise
Assessment
Differential diagnosis
- Other sedative overdose (alcohol, benzodiazepines, opioids)
- Organic coma (hypoglycaemia, head injury, post-ictal, intracranial event)
- Mixed-drug intoxication (common in chemsex settings)
- Alcohol or benzodiazepine withdrawal (for the withdrawal picture)
- Sepsis or metabolic encephalopathy
Investigations
- Capillary glucose, GCS and continuous observations
- ABG/VBG and capnography (hypoventilation)
- ECG and cardiac monitoring
- Bloods: U&E, FBC, CK, glucose; toxicology and alcohol/paracetamol
- CT head if coma not explained or focal signs
Management
- Support airway and breathing — position, oxygen, monitor SpO2 and CO2; intubate if unable to protect airway
- Avoid naloxone/flumazenil as diagnostic (ineffective for GHB, may precipitate problems)
- Observe closely — GHB coma typically resolves abruptly within 2-6 hours
- Screen for co-ingestants (opioids, stimulants) in chemsex presentations
- For withdrawal: recognise early (anxiety, tremor, tachycardia, autonomic instability progressing to delirium/seizures)
- Treat withdrawal with high-dose benzodiazepines, escalating as needed; consider baclofen
- Use critical care for severe/refractory withdrawal (may need barbiturates/propofol)
- Offer substance-misuse referral and safeguarding assessment
Drugs & doses
Oxygen — high-flow via non-rebreathe mask; support ventilation as needed
Diazepam — 10-20 mg PO/IV repeated for withdrawal, titrated to control (large doses often required)
Lorazepam — 2-4 mg IV for agitation/seizures in withdrawal
Baclofen — 10 mg PO TDS as adjunct in GHB withdrawal
Phenobarbital / propofol — in ICU for benzodiazepine-resistant withdrawal
Disposition
Observe overdose until fully recovered and screen for co-ingestants; admit withdrawal to a monitored/critical-care bed for aggressive benzodiazepine treatment, with substance-misuse and safeguarding referral at discharge.
Complications & pitfalls
- Respiratory arrest and aspiration (overdose)
- Rhabdomyolysis
- Benzodiazepine-resistant withdrawal delirium and seizures
- Cardiovascular instability
- Death from either overdose or untreated withdrawal
Exam pearls
- GHB has a very steep dose-response — recreational and lethal doses are close
- Coma is deep but typically short and self-limiting; supportive airway care is the mainstay
- Withdrawal can be more dangerous than overdose and is benzodiazepine-resistant — use high doses early
- Suspect GHB in sudden deep coma with rapid spontaneous recovery, especially in chemsex contexts
- Always consider co-ingested drugs and safeguarding/exploitation issues
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.